A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
Endeavor Biomedicines, Inc.
Endeavor Biomedicines, Inc.
Memorial Sloan Kettering Cancer Center
Ann & Robert H Lurie Children's Hospital of Chicago
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital